SCHEMBL19132147

SCHEMBL19132147

c1cc(-c2ccc3c4ccccc4n(-c4cc5ccccc5c5ccccc45)c3c2)cc(-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
CYP1A2 P05177 2/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
TDP1 Q9NUW8 1/20 0.36
IL1R1 P14778 1/20 0.33
KMT2A Q03164 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MEN1 O00255 2/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
HPRT1 P00492 2/20 0.31
ERBB2 P04626 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22505116 0.97 L3MBTL1 (0.42) L3MBTL1KDM4EATMCYP1A2CYP2C9
SCHEMBL19769406 0.94 L3MBTL1 (0.43) L3MBTL1KDM4EATMCYP1A2CYP2C9
SCHEMBL19769437 0.94 L3MBTL1 (0.43) L3MBTL1KDM4EATMCYP1A2CYP2C9
SCHEMBL23072400 0.92 L3MBTL1 (0.42) L3MBTL1KDM4EATMCYP1A2CYP2C9
SCHEMBL15480218 0.92 L3MBTL1 (0.51) L3MBTL1KDM4EATMCYP1A2CYP2C9
SCHEMBL20149429 0.90 CYP1A2 (0.45) L3MBTL1KDM4EATMCYP1A2CYP2C9
SCHEMBL19769582 0.90 L3MBTL1 (0.44) L3MBTL1KDM4EATMCYP1A2CYP2C9
SCHEMBL15479799 0.90 L3MBTL1 (0.42) L3MBTL1KDM4EATMCYP1A2CYP2C9
SCHEMBL24241344 0.90 L3MBTL1 (0.39) L3MBTL1KDM4EATMCYP1A2CYP2C9
SCHEMBL15479811 0.90 L3MBTL1 (0.42) L3MBTL1KDM4EATMCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11075343-B2 Organic light emitting compounds and organic light emitting devices including the same SFC CO., LTD. (KR) 2021-07-27 US disclosed
US-20170207397-A1 ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME SFC CO., LTD. (KR) 2017-07-20 US disclosed
US-20170207397-A1 ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME SFC CO., LTD. (KR) 2017-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11075343-B2 Organic light emitting compounds and organic light emitting devices including the same HARS1, ALDH1A2, NR2E3 L3MBTL1 562/4885KDM4E 3813/4885ATM 4125/4885
US-20170207397-A1 ORGANIC LIGHT EMITTING COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICES INCLUDING THE SAME HARS1, ALDH1A2, ALDH1A3 L3MBTL1 451/4885KDM4E 3906/4885ATM 4456/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.